Caris Life Sciences Inc (CAI) Stock Price, Quote & News

Company Profile

Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and machine learning algorithms. The company's molecular profiling services portfolio includes MI Profile, a tissue-based molecular profiling solution; and Caris Assure, a blood-based molecular profiling solution for cancer treatment. It also offers pharm...

Industry: Biotechnology

Sector: Healthcare

Phone: 866 771 8946

Fax: 866 479 4925

Website: www.carislifesciences.com

Address:

750 West John Carpenter Freeway, Suite 800, Irving, United States

Jasooon Feb. 22 at 3:52 AM

$CAI owner-led companies have historically outperform peers

0 · Reply

Jasooon Feb. 22 at 3:17 AM

$CAI they have coverage on their tests. Strong growth rates and it is capital light and cash positive because of coverage. All they have to do is make sure the commercial team keeps on operating.

0 · Reply

Jasooon Feb. 22 at 3:16 AM

$CAI what am I missing here?

0 · Reply

Jasooon Feb. 22 at 3:11 AM

$CAI biopharma is in, why aren't you?

0 · Reply

Jasooon Feb. 22 at 3:10 AM

$CAI why aren't we more excited about this?

0 · Reply

appayip Feb. 20 at 3:20 PM

$CAI is it dropping because of Grail?

0 · Reply

Dietl Feb. 19 at 11:23 PM

$CAI what is happening here?

0 · Reply

OfficialStocktwitsUser Feb. 18 at 6:02 PM

$CAI RSI: 22.53, MACD: -1.4668 Vol: 2.02, MA20: 23.19, MA50: 25.74 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

Ron12341 Feb. 17 at 1:01 PM

$CAI $26 coverage by Baird. Fairly low. Actually the lowest of all analysts, but still close to 30% from current stock price. Incremental positive.

0 · Reply

erevnon Feb. 17 at 10:45 AM

Baird initiates coverage on Caris Life Sciences $CAI at Outperform rating and announces a price target of https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

Caris Life Sciences Files Registration Statement for Proposed Initial Public Offering

May 23, 2025, 5:12 PM EDT - 9 months ago

Caris Life Sciences discloses rise in revenue in US IPO filing

May 23, 2025, 4:22 PM EDT - 9 months ago

Oncology precision medicine platform Caris Life Sciences files for an estimated $300 million IPO

May 23, 2025, 3:27 PM EDT - 9 months ago

Caris Life Sciences IPO Registration Document (S-1)

Jasooon Feb. 22 at 3:52 AM

$CAI owner-led companies have historically outperform peers

0 · Reply

Jasooon Feb. 22 at 3:17 AM

$CAI they have coverage on their tests. Strong growth rates and it is capital light and cash positive because of coverage. All they have to do is make sure the commercial team keeps on operating.

0 · Reply

Jasooon Feb. 22 at 3:16 AM

$CAI what am I missing here?

0 · Reply

Jasooon Feb. 22 at 3:11 AM

$CAI biopharma is in, why aren't you?

0 · Reply

Jasooon Feb. 22 at 3:10 AM

$CAI why aren't we more excited about this?

0 · Reply

appayip Feb. 20 at 3:20 PM

$CAI is it dropping because of Grail?

0 · Reply

Dietl Feb. 19 at 11:23 PM

$CAI what is happening here?

0 · Reply

OfficialStocktwitsUser Feb. 18 at 6:02 PM

0 · Reply

Ron12341 Feb. 17 at 1:01 PM

$CAI $26 coverage by Baird. Fairly low. Actually the lowest of all analysts, but still close to 30% from current stock price. Incremental positive.

0 · Reply

erevnon Feb. 17 at 10:45 AM

Baird initiates coverage on Caris Life Sciences $CAI at Outperform rating and announces a price target of https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

Spks Feb. 15 at 12:43 PM

$CAI such an obvious future winner here.

0 · Reply

Ron12341 Feb. 11 at 5:53 PM

$CAI Trading at almost 8 times sales. For this type of growth it’s a true steal. Should be trading at $40 not $20.

0 · Reply

SuperGreenToday Feb. 10 at 10:20 PM

$CAI Share Price: $22.17 Contract Selected: Jul 17, 2026 $25 Calls Buy Zone: $1.19 – $1.47 Target Zone: $1.90 – $2.32 Potential Upside: 51% ROI Time to Expiration: 156 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

Ron12341 Feb. 10 at 2:35 AM

$CAI Need coverage and some PR from company

0 · Reply

Dietl Feb. 5 at 12:58 PM

$CAI Guggenheim $36

0 · Reply

Ron12341 Feb. 4 at 9:46 PM

$CAI down 35K in about month. We need some coverage to get this going. A true Gem.

1 · Reply

OfficialStocktwitsUser Feb. 3 at 8:51 PM

$CAI RSI: 29.45, MACD: -0.9187 Vol: 1.68, MA20: 26.08, MA50: 26.59 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

Ron12341 Jan. 30 at 8:54 PM

$CAI About to test 52 weeks low. We need news from management not to be in free fall mode.

1 · Reply

SuperGreenToday Jan. 29 at 11:12 PM

$CAI Share Price: $25.20 Contract Selected: Jul 17, 2026 $25 Calls Buy Zone: $3.06 – $3.78 Target Zone: $5.33 – $6.52 Potential Upside: 65% ROI Time to Expiration: 168 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

Ron12341 Jan. 29 at 10:49 PM

$CAI it’s ping pong - $25-$27. We need to stay above $25. It will be prudent to break above $27.

0 · Reply

Ron12341 Jan. 29 at 5:53 PM

$CAI What a blood bath…tough day

1 · Reply

Dietl Jan. 28 at 11:48 PM

$CAI 2026 forecast

0 · Reply

Market Cap	5.51B
Revenue (ttm)	294.01M
Net Income (ttm)	27.73M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	64.49
Profit Margin	9.43%
Debt to Equity Ratio	0.79

Volume	3,637,300
Avg Vol	2,305,872
Day's Range	N/A - N/A
Shares Out	282.15M
Stochastic %K	18%
Beta	N/A
Analysts	Strong Sell
Price Target	$36.11